Palavras-chave
Neoplasia de Mama
Transtornos Mentais
Como Citar
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Resumo
Objetivo: Analisar a influência mútua entre o tratamento do câncer de mama e os transtornos mentais em pacientes idosas. Métodos: Trata-se de uma revisão integrativa, na qual foram selecionados nas bases de dados PubMed, Scopus e BVS, artigos científicos publicados nos últimos cinco anos, utilizando os descritores “aged women”, “treatment”, “breast cancer” e “mental disorders”. A busca integrativa criteriosa resultou em 1400 artigos. Após a aplicação dos critérios de elegibilidade, foram incluídos 20 estudos. Resultados: Os artigos encontrados foram divididos em dois grupos: no primeiro grupo foi avaliado aumento na prevalência de depressão e ansiedade e impacto negativo na função cognitiva em pacientes em tratamento de câncer de mama; já no segundo grupo, os transtornos mentais tiveram associação com o aumento da mortalidade por câncer de mama e piores desfechos da doença (aumento do tempo de hospitalização e risco de infecções pós-cirúrgicas), sendo averiguada associação de fármacos psiquiátricos com aumento do risco de surgimento de câncer de mama. Considerações finais: É evidente a influência mútua entre o tratamento de câncer de mama e os transtornos mentais em pacientes idosas, de forma geral apresentando impactos bilateralmente negativos.
Referências
AHLGRÉN-RIMPILÄINEN AJ, et al. Excess mortality from breast cancer in female breast cancer patients with severe mental illness. Psychiatry research, 2020; 286; 112801: 112801.
ÁLVAREZ-PARDO S, et al. Related factors with depression and anxiety in mastectomized women breast cancer survivors. International journal of environmental research and public health, 2023; 20: 4.
BEDILLION MF, et al. A Cancer treatment effects on cognition and depression: The moderating role of physical activity. Breast (Edinburgh, Scotland), 2019; 44: 73–80.
BLANCHETTE PS, et al. The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada. Journal of geriatric oncology, 2020; 11; 7: 1132–1137.
BREIDENBACH C, et al. Prevalence and determinants of anxiety and depression in long-term breast cancer survivors. BMC psychiatry, 2022; 22; 1: 101.
BUSCARIOLLO DL, et al. Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women. Breast Cancer Research and Treatment, 2018; 173: 709-717.
CARREIRA H, et al. Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom. PLoS medicine, 2021; 18: 1003504.
CHU RYK, et al. Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades. Psychiatry research, 2023; 326: 115287.
DALTON SO, et al. Impact of schizophrenia and related disorders on mortality from breast cancer: A population-based cohort study in Denmark, 1995-2011. Breast (Edinburgh, Scotland), 2018; 40: 170–176.
DESHPANDE AJ, et al. Examining the relationship between severe persistent mental illness and surgical outcomes in women undergoing mastectomy for breast cancer. American journal of surgery, 2023; 226; 1: 4–10.
FOND G, et al. End of life breast cancer care in women with severe mental illnesses. Scientific reports, 2021;11: 10167.
GUIMOND A-J, et al. Clusters of psychological symptoms in breast cancer: Is there a common psychological mechanism? Cancer nursing, 2020; 43: 343–353.
HASKINS CB, et al. Impact of preexisting mental illness on breast cancer endocrine therapy adherence. Breast cancer research and treatment, 2019; 174: 197–20
HASKINS CB, et al. Effects of previous medication regimen factors and bipolar and psychotic disorders on breast cancer endocrine therapy adherence. Clinical breast cancer, 2020; 20 e261–e280.
HORMOZI M, et al. Investigating relationship between pre- and post- chemotherapy cognitive performance with levels of depression and anxiety in breast cancer patients: A cross-sectional study. Asian Pacific journal of cancer prevention: APJCP, 2019; 20: 3831–3837
JOMAR RT, et al. Fatores associados ao tempo para submissão ao primeiro tratamento do câncer de mama. Ciência & Saúde Coletiva, 2023; 28: 2155–2164.
LEAL FR, et al. Prevalência de depressão e ansiedade e sua relação com esperança em pacientes oncológicos em tratamento quimioterápico. rmmg.org, 2021; 31: 61–66.
MARTIN C, et al. Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort study. Journal of geriatric oncology, 2021; 12; 5: 705–713.
MARTIN C, et al. Caregiver experiences of making treatment decisions for older women with breast cancer and dementia. Health & social care in the community, 2022; 30; 5: e2058–e2068.
MONTILLA D, et al. Mortalidade por câncer de mama em mulheres idosas no Brasil e nas grandes regiões: uso do SISAP-Idoso. Reciis, 2023; 17: 372–386.
PIROTH MD, et al. Anxiety and depression in patients with breast cancer undergoing radiotherapy: the role of intelligence, life history, and social support-preliminary results from a monocentric analysis. Strahlentherapie Und Onkologie: Organ Der Deutschen Rontgengesellschaft. 2022; 198; 4; 388–396.
SHEN Q, et al. Psychiatric disorders and cardiovascular diseases during the diagnostic workup of potential breast cancer: a population-based cohort study in Skåne, Sweden. Breast cancer research: BCR, 2019; 21: 139.
TAIPALE H, et al. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. The lancet. Psychiatry, 2021; 8: 883–891.